Sir Tom McKillop

Sir Tom McKillop began his career with ICI in 1969 after post-doctoral research work in Paris.

Within ICI Pharmaceuticals Division he held a number of increasingly senior research and development positions, including Director of Research in France, General Manager (Research) and then General Manager (Development), before his appointment in 1989 as Technical Director of ICI Pharmaceuticals, a role in which he had global responsibility for Research, Development, Medical and Production.

In 1992 he was appointed Deputy CEO and in 1994 became CEO of Zeneca Pharmaceuticals (Zeneca having demerged from ICI in 1993). In 1999 he led the merger of Astra and Zeneca, becoming Chief Executive of AstraZeneca plc, a position he held until retiring at the end of 2005.

Board Mandates

Sir Tom is a Board Member of Laboratorios Almirall SA and UCB SA. Until recently he was the Chairman of the Royal Bank of Scotland and a Non-Executive Director of BP.

He has been Senior Non-Executive Director of Lloyds TSB Group and a Non-Executive Director of Amersham International before it was acquired by General Electric.

He has been President of the European Federation of Pharmaceutical Industries and Associations, Chairman of the Pharmaceutical Industry Task Force and a member of both the European Round Table of Industrialists and the European Financial Roundtable.

Sir Tom is currently President of the Science Council.

Awards

Sir Tom has received many scholarly awards and fellowships. He is both a Fellow of The Royal Society and the Royal Society of Edinburgh, a Fellow of The Academy of Medical Sciences, an honorary Fellow of The Royal Society of Chemistry, an honorary Fellow of The Institute of Chemical Engineers and a Companion of The Institute of Management.